nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamibarotene—RARB—prostate gland—urinary bladder cancer	0.0703	0.232	CbGeAlD
Tamibarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.0617	0.0885	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.0591	0.0848	CbGpPWpGaD
Tamibarotene—RARA—prostate gland—urinary bladder cancer	0.0539	0.178	CbGeAlD
Tamibarotene—RARB—female reproductive system—urinary bladder cancer	0.0383	0.127	CbGeAlD
Tamibarotene—RARA—renal system—urinary bladder cancer	0.0367	0.121	CbGeAlD
Tamibarotene—RARB—vagina—urinary bladder cancer	0.0347	0.114	CbGeAlD
Tamibarotene—RARA—female reproductive system—urinary bladder cancer	0.0294	0.0971	CbGeAlD
Tamibarotene—RARB—Nuclear Receptors—ESR2—urinary bladder cancer	0.024	0.0344	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptors—ESR2—urinary bladder cancer	0.023	0.033	CbGpPWpGaD
Tamibarotene—RARB—lymph node—urinary bladder cancer	0.0224	0.074	CbGeAlD
Tamibarotene—RARB—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.019	0.0272	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.0182	0.0261	CbGpPWpGaD
Tamibarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—urinary bladder cancer	0.018	0.0258	CbGpPWpGaD
Tamibarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—urinary bladder cancer	0.0173	0.0248	CbGpPWpGaD
Tamibarotene—RARA—lymph node—urinary bladder cancer	0.0172	0.0568	CbGeAlD
Tamibarotene—RARB—Retinoic acid receptors-mediated signaling—CREBBP—urinary bladder cancer	0.0154	0.0221	CbGpPWpGaD
Tamibarotene—RARA—Retinoic acid receptors-mediated signaling—CREBBP—urinary bladder cancer	0.0148	0.0212	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptors—ESR1—urinary bladder cancer	0.0146	0.0209	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.0145	0.0208	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptors—ESR1—urinary bladder cancer	0.014	0.02	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.0139	0.02	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptors—PPARG—urinary bladder cancer	0.0133	0.0191	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptors—PPARG—urinary bladder cancer	0.0127	0.0183	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.0115	0.0165	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.011	0.0158	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.0108	0.0155	CbGpPWpGaD
Tamibarotene—RARB—Retinoic acid receptors-mediated signaling—EP300—urinary bladder cancer	0.0105	0.0151	CbGpPWpGaD
Tamibarotene—RARB—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.0105	0.0151	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.0104	0.0149	CbGpPWpGaD
Tamibarotene—RARA—Retinoic acid receptors-mediated signaling—EP300—urinary bladder cancer	0.0101	0.0144	CbGpPWpGaD
Tamibarotene—RARA—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.0101	0.0144	CbGpPWpGaD
Tamibarotene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TNF—urinary bladder cancer	0.00956	0.0137	CbGpPWpGaD
Tamibarotene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TNF—urinary bladder cancer	0.00916	0.0131	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.00824	0.0118	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.00819	0.0118	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.0079	0.0113	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.00785	0.0113	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—NCOR1—urinary bladder cancer	0.00664	0.00953	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.0066	0.00946	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.00632	0.00907	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—FAS—urinary bladder cancer	0.00596	0.00854	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.00525	0.00753	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.00515	0.00739	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.00503	0.00722	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.00494	0.00709	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—PPARG—urinary bladder cancer	0.00476	0.00683	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.00457	0.00655	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—RB1—urinary bladder cancer	0.00456	0.00654	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—IGF1—urinary bladder cancer	0.00452	0.00648	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.00438	0.00628	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.00403	0.00579	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.00402	0.00576	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.004	0.00574	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.00387	0.00555	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.00385	0.00553	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.00384	0.0055	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.00351	0.00503	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.00346	0.00497	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.00336	0.00482	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.00332	0.00476	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.00328	0.0047	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—CDKN1A—urinary bladder cancer	0.00327	0.0047	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.00314	0.00451	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.00294	0.00421	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.00287	0.00412	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.00282	0.00404	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.00275	0.00395	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.00259	0.00372	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.00253	0.00363	CbGpPWpGaD
Tamibarotene—RARA—Adipogenesis—TNF—urinary bladder cancer	0.00253	0.00363	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.00251	0.0036	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.0025	0.00359	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.00249	0.00357	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.00243	0.00348	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.00241	0.00345	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.0024	0.00344	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.00239	0.00343	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.00232	0.00333	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.00229	0.00328	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.00223	0.00319	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.00208	0.00299	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.00204	0.00292	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	0.002	0.00286	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.00199	0.00285	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	0.00195	0.0028	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.00194	0.00278	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.00192	0.00276	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.00191	0.00273	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	0.00186	0.00267	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	0.00184	0.00264	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.00181	0.0026	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—SMC1A—urinary bladder cancer	0.00181	0.0026	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.00174	0.0025	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.00174	0.00249	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—SMC1A—urinary bladder cancer	0.00174	0.00249	CbGpPWpGaD
Tamibarotene—RARB—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.00171	0.00245	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.00167	0.0024	CbGpPWpGaD
Tamibarotene—RARA—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	0.00164	0.00235	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—ESR2—urinary bladder cancer	0.00158	0.00226	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—ESR2—urinary bladder cancer	0.00151	0.00217	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—NCOR1—urinary bladder cancer	0.00122	0.00175	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—NCOR1—urinary bladder cancer	0.00117	0.00168	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—ERCC2—urinary bladder cancer	0.00115	0.00164	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—ERCC2—urinary bladder cancer	0.0011	0.00158	CbGpPWpGaD
Tamibarotene—RARB—Generic Transcription Pathway—MYC—urinary bladder cancer	0.00103	0.00148	CbGpPWpGaD
Tamibarotene—RARA—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000991	0.00142	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—ESR1—urinary bladder cancer	0.000957	0.00137	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—ESR1—urinary bladder cancer	0.000917	0.00132	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—PPARG—urinary bladder cancer	0.000873	0.00125	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—CREBBP—urinary bladder cancer	0.000839	0.0012	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—PPARG—urinary bladder cancer	0.000837	0.0012	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—CREBBP—urinary bladder cancer	0.000804	0.00115	CbGpPWpGaD
Tamibarotene—RARB—Gene Expression—MYC—urinary bladder cancer	0.000498	0.000714	CbGpPWpGaD
Tamibarotene—RARA—Gene Expression—MYC—urinary bladder cancer	0.000477	0.000685	CbGpPWpGaD
